Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fighting for menstrual equity through period product pantries.
Glayzer EJ, Jennings CT, Schlaeger JM, Watkins B, Rieseler A, Ray M, Lee A, Glayzer JE. Glayzer EJ, et al. Among authors: jennings ct. Womens Health (Lond). 2024 Jan-Dec;20:17455057241281459. doi: 10.1177/17455057241281459. Womens Health (Lond). 2024. PMID: 39290126 Free PMC article. Review.
Longer-term survival, quality of life, and cost-effectiveness of conservative versus liberal oxygenation targets in critically ill children: a pre-specified analysis from Oxy-PICU, a multicentre, open, parallel-group, randomised controlled trial.
Moler-Zapata S, Peters MJ, Gould DW, Giallongo E, Orzol M, Ray S, Thomas K, Chang I, O'Neill L, Agbeko R, Au C, Draper E, Elliot-Major L, Lampro L, Pappachan J, Peters S, Ramnarayan P, Rowan KM, Harrison DA, Mouncey PR, Sadique Z; Oxy-PICU Investigators of the Paediatric Critical Care Society Study Group (PCCS-SG). Moler-Zapata S, et al. Lancet Child Adolesc Health. 2025 Jan;9(1):16-24. doi: 10.1016/S2352-4642(24)00294-3. Lancet Child Adolesc Health. 2025. PMID: 39701658 Free article. Clinical Trial.
Development of a Digital Health Intervention for the Secondary Prevention of Cardiovascular Disease (INTERCEPT): Co-Design and Usability Testing Study.
Gibson I, Neubeck L, Corcoran M, Morland C, Donovan S, Jones J, Costello C, Hynes L, Harris A, Harrahill M, Lillis M, Atrey A, Ski CF, Savickas V, Byrne M, Murphy AW, McEvoy JW, Wood D, Jennings C. Gibson I, et al. Among authors: jennings c. JMIR Hum Factors. 2024 Oct 23;11:e63707. doi: 10.2196/63707. JMIR Hum Factors. 2024. PMID: 39441626 Free PMC article.
Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.
Kotseva K, Jennings C, Bassett P, Adamska A, Hobbs R, Wood D; ASPIRE-3-PREVENT Investigators. Kotseva K, et al. Among authors: jennings c. Open Heart. 2024 Oct 15;11(2):e002704. doi: 10.1136/openhrt-2024-002704. Open Heart. 2024. PMID: 39414309 Free PMC article.
Cardiac rehabilitation and secondary prevention of CVD: time to think about cardiovascular health rather than rehabilitation.
Redfern J, Gallagher R, Maiorana A, Candelaria D, Hollings M, Gauci S, O'Neil A, Chaseling GK, Zhang L, Thomas EE, Ghisi GLM, Gibson I, Hyun K, Beatty A, Briffa T, Taylor RS, Arena R, Jennings C, Wood D, Grace SL. Redfern J, et al. Among authors: jennings c. NPJ Cardiovasc Health. 2024;1(1):22. doi: 10.1038/s44325-024-00017-7. Epub 2024 Sep 30. NPJ Cardiovasc Health. 2024. PMID: 39359645 Free PMC article. Review.
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
714 results